Oct 28, 2015
Medical Research Visionaries Convene in New York, Present Model Solutions to Life Sciences’ Most Pressing Challenges
WASHINGTON – More than 700 medical research innovators from 30 states and six countries will come together Nov. 1-3 in New York for the 7th annual Partnering for Cures meeting. Convened by FasterCures, a Washington-based center of the Milken Institute, this unique conference assembles senior government officials, patient advocates, scientists, major investors, industry CEOs and philanthropists to forge the partnerships needed to accelerate medical progress.
“Opportunity is upon us, and the timing could not be more critical,” said FasterCures Executive Director Margaret Anderson. “As national policymakers cross the aisle to advance the search for cures, patient input and creative problem-solving are at a premium. That’s what Partnering for Cures is all about—bringing innovative ideas, strategic capital and disruptive thinkers together to transform the system so that every disease, and every patient, can benefit.”
This year’s conference will feature a new, evolved format that emphasizes hands-on problem solving through a mix of facilitated workshops, town-hall style discussions, hot-button panels and fast-paced presentations, all geared toward highlighting patient-centered solutions to the thorniest challenges in research and development.
Among the speakers:
- Robert Califf, Deputy Commissioner, Medical Products and Tobacco, U.S. Food and Drug Administration
- Francis Collins, Director, National Institutes of Health
- Roslyn Schneider, Global Patient Affairs Lead, Pfizer Medical, Pfizer
- Ben Heywood, Co-Founder and President, PatientsLikeMe
- Alph Bingham, Founder and Board Member, Innocentive
- Nancy Brown, CEO, American Heart Association
- Richard Pops, Chairman and CEO, Alkermes
- Linda Avey, Co-Founder & CEO, We Are Curious, Inc.
- Louis DeGennaro, President and CEO, Leukemia & Lymphoma Society
- Stephanie Devaney, Project Manager, Precision Medicine Initiative, White House Office of Chief of Staff
- Joe Selby, Executive Director, Patient-Centered Outcomes Research Institute
- William Reeve, Member, Board of Directors, Christopher and Dana Reeve Foundation
- Clifford Hudis, Vice President for Government Relations and Chief Advocacy Officer; Chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center
- Corinna Lathan, Founder and CEO, AnthroTronix
- Stacey Chang, Executive Director, Design Institute for Health, Dell Medical School & College of Fine Arts, University of Texas at Austin
- Rudolph Tanzi, Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Vice Chair, Neurology Research, Massachusetts General Hospital
- Andrea Ferris, President and Chairman, LUNGevity Foundation
- Tony Coles, Chairman and CEO, Yumanity Therapeutics
- Christopher Austin, Director, National Center for Advancing Translational Sciences, National Institutes of Health
- Plavi Mittal, President and CEO, Jain Foundation
- And many more
Panel sessions include:
- Gimme my %^&* data
- Partnering with patients on value, coverage, and reimbursement
- Of the person, by the person, for the person: The road to precision medicine
- Redefining discovery for the 21st century
- Channeling the power of the "P" in patient-centricity
- Stop talking and start doing something: What will you do to accelerate cures?
- And many more
Held at the Grand Hyatt New York, Partnering for Cures is open to the public and to members of the media (registration is required). For general registration information, go to www.partneringforcures.org/registration. Members of the press may apply here to receive complimentary registration.
More information, including a full program and a list of confirmed speakers, is available at www.partneringforcures.org.
The Milken Institute is a nonprofit, nonpartisan think tank determined to increase global prosperity by advancing collaborative solutions that widen access to capital, create jobs and improve health. It conducts data-driven research, convenes action-oriented meetings and promotes meaningful policy initiatives.